NL193639B - Farmaceutisch aanvaardbare zouten van [3S(Z)]-2[[[1-(2-aminothiazolyl-4)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy) -3-azetidinyl]amino]-2-oxoethylideen]amino]-oxy]azijnzuur. - Google Patents

Farmaceutisch aanvaardbare zouten van [3S(Z)]-2[[[1-(2-aminothiazolyl-4)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy) -3-azetidinyl]amino]-2-oxoethylideen]amino]-oxy]azijnzuur.

Info

Publication number
NL193639B
NL193639B NL8703047A NL8703047A NL193639B NL 193639 B NL193639 B NL 193639B NL 8703047 A NL8703047 A NL 8703047A NL 8703047 A NL8703047 A NL 8703047A NL 193639 B NL193639 B NL 193639B
Authority
NL
Netherlands
Prior art keywords
amino
aminothiazolyl
oxoethylidene
sulfooxy
azetidinyl
Prior art date
Application number
NL8703047A
Other languages
English (en)
Other versions
NL8703047A (nl
NL193639C (nl
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of NL8703047A publication Critical patent/NL8703047A/nl
Publication of NL193639B publication Critical patent/NL193639B/nl
Application granted granted Critical
Publication of NL193639C publication Critical patent/NL193639C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
NL8703047A 1986-12-19 1987-12-16 Farmaceutisch aanvaardbare zouten van [3S(Z)]-2[[[1-(2-aminothiazolyl-4)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy) -3-azetidinyl]amino]-2-oxoethylideen]amino]-oxy]azijnzuur. NL193639C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/944,283 US4751220A (en) 1986-12-19 1986-12-19 Crystalline salts of [3S(Z)]-2[[[1-(2-amino-4-thiazolyl)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl]amino]-2-oxoethylidene]-amino]oxy]acetic acid
US94428386 1986-12-19

Publications (3)

Publication Number Publication Date
NL8703047A NL8703047A (nl) 1988-07-18
NL193639B true NL193639B (nl) 2000-01-03
NL193639C NL193639C (nl) 2000-05-04

Family

ID=25481130

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8703047A NL193639C (nl) 1986-12-19 1987-12-16 Farmaceutisch aanvaardbare zouten van [3S(Z)]-2[[[1-(2-aminothiazolyl-4)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy) -3-azetidinyl]amino]-2-oxoethylideen]amino]-oxy]azijnzuur.

Country Status (25)

Country Link
US (1) US4751220A (nl)
JP (1) JP2511083B2 (nl)
KR (1) KR960007534B1 (nl)
AU (1) AU600536B2 (nl)
BE (1) BE1000625A3 (nl)
CA (1) CA1296717C (nl)
CH (1) CH674009A5 (nl)
DE (1) DE3743111C2 (nl)
DK (1) DK671487A (nl)
ES (1) ES2007766A6 (nl)
FI (1) FI91757C (nl)
FR (1) FR2610627B1 (nl)
GB (1) GB2199033B (nl)
GR (1) GR871937B (nl)
HU (1) HU197568B (nl)
IE (1) IE61325B1 (nl)
IL (1) IL84521A (nl)
IT (1) IT1233457B (nl)
LU (1) LU87076A1 (nl)
NL (1) NL193639C (nl)
NZ (1) NZ222599A (nl)
PH (1) PH23170A (nl)
PT (1) PT86403B (nl)
SE (1) SE467782B (nl)
ZA (1) ZA879031B (nl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567592A (en) * 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
US7041650B2 (en) * 2001-07-09 2006-05-09 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivative salts
US7087418B2 (en) * 2001-12-19 2006-08-08 Bristol-Myers Squibb Company Pichia pastoris formate dehydrogenase and uses therefor
CN101724000B (zh) * 2008-10-29 2012-05-30 广东东阳光药业有限公司 一种红霉素的结晶方法
CN113754651B (zh) * 2020-06-02 2023-04-18 中国医学科学院医药生物技术研究所 一种β-内酰胺化合物、其用途及其制备方法
CN113975396B (zh) * 2021-11-09 2022-11-29 中国医学科学院医药生物技术研究所 包含β-内酰胺类化合物的药物组合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES376380A1 (es) * 1970-01-30 1972-04-16 Roger Lab Procedimiento de obtencion de un nuevo derivado de eritro- micina.
AU8364875A (en) * 1974-08-21 1977-02-10 Hoffmann La Roche Choline and n-methyl-d-glucamine salts of amoxycillin
US4337197A (en) * 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates
US4533660A (en) * 1980-10-31 1985-08-06 E. R. Squibb & Sons, Inc. Antibacterial O-sulfated β-lactam hydroxamic acids
US4638061A (en) * 1985-01-28 1987-01-20 E. R. Squibb & Sons, Inc. [3S(Z)]-2-[[[1-(2-amino-4-thiazolyl)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl]amino]-2-oxoethylidene]-amino]oxy] acetic acid and intermediate

Also Published As

Publication number Publication date
GB2199033B (en) 1990-10-24
US4751220A (en) 1988-06-14
HUT45998A (en) 1988-09-28
BE1000625A3 (fr) 1989-02-21
HU197568B (en) 1989-04-28
FI91757B (fi) 1994-04-29
FI875159A (fi) 1988-06-20
SE467782B (sv) 1992-09-14
JPS63165381A (ja) 1988-07-08
FI875159A0 (fi) 1987-11-23
IL84521A (en) 1992-02-16
DE3743111A1 (de) 1988-06-30
GR871937B (en) 1988-04-26
DE3743111C2 (de) 1996-04-04
KR960007534B1 (ko) 1996-06-05
DK671487D0 (da) 1987-12-18
ZA879031B (nl) 1988-05-27
NZ222599A (en) 1989-09-27
CA1296717C (en) 1992-03-03
PH23170A (en) 1989-05-19
GB8727048D0 (en) 1987-12-23
GB2199033A (en) 1988-06-29
SE8705068D0 (sv) 1987-12-18
LU87076A1 (fr) 1988-07-14
IE61325B1 (en) 1994-11-02
ES2007766A6 (es) 1989-07-01
NL8703047A (nl) 1988-07-18
AU8185787A (en) 1988-06-23
AU600536B2 (en) 1990-08-16
IT8722908A0 (it) 1987-12-07
FI91757C (fi) 1994-08-10
JP2511083B2 (ja) 1996-06-26
PT86403A (en) 1988-01-01
FR2610627A1 (fr) 1988-08-12
IT1233457B (it) 1992-04-02
IL84521A0 (en) 1988-04-29
KR880007528A (ko) 1988-08-27
DK671487A (da) 1988-06-20
NL193639C (nl) 2000-05-04
IE873447L (en) 1988-06-19
PT86403B (pt) 1990-11-20
SE8705068L (sv) 1988-06-20
FR2610627B1 (fr) 1989-12-01
CH674009A5 (nl) 1990-04-30

Similar Documents

Publication Publication Date Title
FI88037B (fi) Foerfarande foer framstaellning av farmaceutiskt vaerdefullt kristallint (4r,5s,6s,8r,2's,4's)-3-/4-(2-dimetylaminokarbonyl)-pyrrolidinyltio/-4-metyl-6-(1-hydroxietyl)-1-azabicyklo-/3,2,0/-hept-2-en-7-on-2-karboxylsyratrihydrat
NO871408D0 (no) Forbedringer ved farmasoeytiske akseptable salter.
AU576944B2 (en) 8-chlorodibenz (b,f) (1,4) oxazepine-10 (11h) -carboxylic acid 2-(sulphinyl and sulphonyl - containing acyl) hydrazides
EP0485218A3 (en) Process for preparing (1'r,3s)-3-(1'-hydroxy-ethyl)-azetidin-2-one and derivatives thereof
NO170330C (no) Fremgangsmaate for fremstilling av vesentlig optisk rent monohydrat av s-(-)-propyl-2',6'-pipekoloksylididhydroklorid
FI91964C (fi) Menetelmä uusien, farmaseuttisesti aktiivisten 1-(hydroksistyryyli)-5H-2,3-bentsodiatsepiinijohdannaisten valmistamiseksi
NL193639B (nl) Farmaceutisch aanvaardbare zouten van [3S(Z)]-2[[[1-(2-aminothiazolyl-4)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy) -3-azetidinyl]amino]-2-oxoethylideen]amino]-oxy]azijnzuur.
AU599401B2 (en) Amino acid derivatives
SE8600355D0 (sv) Forfarande for framstellning av 4,4-dialkyl-2-azetidinoner
FI890678A (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi
AR243159A1 (es) Procedimiento de preparacion de acido 1-(3-mercapto-(2s)-metilpropionil)-pirrolidin-(2s)-carboxilico o sus sales farmaceuticamente aceptables.
ITMI930492A1 (it) Procedimento per preparare acido 1-(25)-metil-3-mercaptopropionil pirrolidina-(2s)-carbossilico.
IT8621066A0 (it) Procedimento per la preparazione di composti eterociclici azotati.
FI894813A (fi) Menetelmä terapeuttisesti aktiivisten 2-metoksikarbonyylisubstituoitujen N,N'-di(trimetoksibentsoyyli)piperatsiinijohdannaisten valmistamiseksi
AU6042686A (en) 1,4,5,6,7,8-hexahydro-(substituted) phenyl-1,7- napthyridine-3-carboxylic acid derivatives
IL135149A0 (en) Process for preparing (2r, 3s)-3-(4-alkoxyphenyl) glycidic acid esters
FI885033A (fi) Menetelmä 1,5-bentsotiatsepiinijohdannaisten valmistamiseksi
IT8921175A0 (it) Procedimento per la preparazione di acido metossiacetico.
ATE85615T1 (de) 3-pyrrolidinylthio-1-azabicyclo(3.2.0>hept-2-en 2-carbonsaeure-derivate.
IE872475L (en) Acetic acid derivatives of 3-aryl-2,1-benzisoxazole
FI883116A (fi) Menetelmä 1,5-bentsotiatsepiinijohdannaisten valmistamiseksi
NO891996L (no) Forbedret fremgangsmaate for fremstilling av 3-((4-brom-2-fluorfenyl)-methyl)-3, 4-dihydro-4-oxo-l-fthalazin-eddiksyre.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V1 Lapsed because of non-payment of the annual fee

Effective date: 20030701